Condition
Classical Hodgkin Lymphoma clinical trials and research
Research outlook What's coming for Hodgkin lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Classical Hodgkin Lymphoma clinical trials that are recruiting, at sites in 12 countries (most in Italy (3), Germany (3), France (2)). By phase: Phase 2 (4), Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 12Countries
Newest Classical Hodgkin Lymphoma clinical trials
All recruiting trials (9)
-
Blood ctDNA testing to monitor treatment in children and young adults with classical Hodgkin lymphoma
This project tests whether a blood test that detects circulating tumor DNA can monitor treatment response and help predict relapse in children and young adults with classical Hodgkin lymphoma.
-
Sintilimab combined with AVD chemotherapy for treating pediatric Hodgkin lymphoma
This study is testing if a new immunotherapy combined with standard chemotherapy can help children and teens with low-to-intermediate risk Hodgkin lymphoma feel better and improve their treatment results.
-
Assessing Prognosis in Hodgkin Lymphoma
This study is trying to find better ways to predict how Hodgkin Lymphoma will progress in patients who have finished treatment or have had a relapse, using new tools and tests to help personalize their care.
-
Using Brentuximab Vedotin to treat newly diagnosed Classical Hodgkin Lymphoma in young patients
This study is testing if a new treatment with Brentuximab vedotin can help young patients with newly diagnosed classical Hodgkin lymphoma feel better while reducing the need for chemotherapy and radiation.
-
Healthy Lifestyle Plan for Lymphoma Survivors
This study is testing whether a special health plan that includes lifestyle changes and nutrition advice can help lymphoma survivors feel better after they've been in remission for a while.
-
Combining pembrolizumab with chemotherapy for relapsed Hodgkin lymphoma
This study is testing if adding pembrolizumab to standard chemotherapy can help people with relapsed Hodgkin lymphoma feel better and have fewer side effects.
-
Individualized immunotherapy for early-stage Hodgkin lymphoma
This study is testing a personalized treatment using a new drug for young people with early-stage Hodgkin lymphoma to see if it can help them avoid harsh chemotherapy and improve their quality of life.
-
Combining pembrolizumab and bendamustine for treating relapsed Hodgkin lymphoma
This study is testing whether combining two drugs, pembrolizumab and bendamustine, can help people with relapsed Hodgkin lymphoma feel better and improve their treatment outcomes.
-
Treatment of advanced solid tumors and lymphomas in children using pembrolizumab
This study is testing if a new immunotherapy drug called pembrolizumab can help shrink or eliminate advanced solid tumors and lymphomas in children aged 12 to 18 who haven't responded to other treatments.
Related topics
Quick answers
How many Classical Hodgkin Lymphoma clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Italy (3 trials), Germany (3 trials), France (2 trials), China (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.